Madison, WI, United States of America

Robert Bradley

This inventor holds 1 USPTO granted patent. Top assignees: Fujifilm Cellular Dynamics, Inc., Fujifilm Holdings America Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Bradley. Retrieved from https://idiyas.com/inventor/robert-bradley-kaqo43jd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Robert Bradley: Advancing Astrocyte Research

Introduction

Robert Bradley is an inventor associated with Madison, Wisconsin. His work includes research on producing astrocytes from induced pluripotent stem cells and exploring their potential uses in neuroscience and cell therapy.

Latest Patents

Bradley is associated with 1 patent, titled “IPSC-derived astrocytes and methods of use thereof.” The patent describes methods for producing neural precursor cells with a glial bias from induced pluripotent cells and differentiating those precursor cells into astrocytes. It also outlines potential uses for the astrocytes in screening assays, models that mimic the human brain, and cell therapy.

Career Highlights

Bradley has been associated with Fujifilm Cellular Dynamics, Inc. and FUJIFILM Holdings America Corporation. His patent reflects work at the intersection of stem-cell research and potential applications in neuroscience.

Collaborations

Bradley’s listed coworkers include Deepika Rajesh and Christie Savic.

Conclusion

Robert Bradley’s patent documents an approach to generating astrocytes from induced pluripotent cells and applying them in research models, screening, and potential cell therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…